Outcomes of patients with cytomegalovirus viremia at the time of liver transplantation

Jackrapong Bruminhent, Raymund R. Razonable

Research output: Contribution to journalArticle

Abstract

Cytomegalovirus (CMV) infection has been associated with poor outcomes after liver transplantation. Whether it is safe to perform transplantation for patients with active CMV viremia is not known. Here we report the outcomes of 6 patients with CMV viremia immediately before or at the time of liver transplantation. Data from these patients indicate that CMV can be adequately controlled with antiviral therapy, although patients appear to be at higher risk for indirect effects of CMV such as other opportunistic infections and liver allograft dysfunction.

Original languageEnglish (US)
Pages (from-to)1029-1033
Number of pages5
JournalLiver Transplantation
Volume20
Issue number9
DOIs
StatePublished - Jan 1 2014

ASJC Scopus subject areas

  • Surgery
  • Hepatology
  • Transplantation

Fingerprint Dive into the research topics of 'Outcomes of patients with cytomegalovirus viremia at the time of liver transplantation'. Together they form a unique fingerprint.

  • Cite this